Renzapride: a new drug for the treatment of constipation in the irritable bowel syndrome

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.17, Iss.11, 2008-11, pp. : 1663-1670

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Cardiovascular Safety Profile of Renzapride, a Novel Treatment for Irritable Bowel Syndrome

By Meyers NL Hickling RI

The Journal of International Medical Research, Vol. 35, Iss. 6, 2007-11 ,pp. : 848-866

Field House Publishing

Access to resources Recommend Favorite

Linaclotide: a novel compound for the treatment of irritable bowel syndrome with constipation

By Rothstein Robin D Friedenberg Frank K

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 15, 2013-10 ,pp. : 2125-2132

Informa Healthcare

Access to resources Recommend Favorite

Linaclotide-a Novel Secretagogue in the Treatment of Irritable Bowel Syndrome with Constipation and Chronic Idiopathic Constipation

Mini Reviews in Medicinal Chemistry, Vol. 13, Iss. 11, 2013-10 ,pp. : 1685-1690

Bentham Science Publishers

Access to resources Recommend Favorite

Lubiprostone: In Constipation-Predominant Irritable Bowel Syndrome

By Carter Natalie J. Scott Lesley J.

Drugs, Vol. 69, Iss. 9, 2009-06 ,pp. : 1229-1237

Adis International

Access to resources Recommend Favorite

Drug Treatment Options for Irritable Bowel Syndrome: Managing for Success

By Dunphy R.C. Verne G.N.

Drugs & Aging, Vol. 18, Iss. 3, 2001-03 ,pp. : 201-211

Adis International

Access to resources Recommend Favorite